Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial

Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 was added to the study record history, and the older v3.6.0 entry was removed from the list.
    Difference
    0.1%
    Check dated 2026-06-27T00:09:45.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-06-12T22:11:53.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision v3.5.5 was added to the study history. The previous revision v3.5.4 was removed from the history.
    Difference
    0.1%
    Check dated 2026-06-05T18:01:43.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.5.4 as the latest entry, and Revision: v3.5.3 has been removed from the record history. This update reflects changes to the page's revision metadata rather than its substantive content.
    Difference
    0.1%
    Check dated 2026-05-15T06:53:04.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor site/version maintenance update rather than a change to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T06:36:01.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:24.000Z thumbnail image

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.